Viewing Study NCT05029895


Ignite Creation Date: 2025-12-24 @ 2:19 PM
Ignite Modification Date: 2025-12-26 @ 10:45 AM
Study NCT ID: NCT05029895
Status: COMPLETED
Last Update Posted: 2025-12-23
First Post: 2021-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-09-29
Start Date Type: ACTUAL
Primary Completion Date: 2025-09-17
Primary Completion Date Type: ACTUAL
Completion Date: 2025-09-17
Completion Date Type: ACTUAL
First Submit Date: 2021-08-30
First Submit QC Date: None
Study First Post Date: 2021-09-01
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-17
Last Update Post Date: 2025-12-23
Last Update Post Date Type: ESTIMATED